Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Express Scripts
AstraZeneca
Johnson and Johnson
Colorcon

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

Hetero Labs Ltd Iii Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for HETERO LABS LTD III, and what generic and branded alternatives to HETERO LABS LTD III drugs are available?

HETERO LABS LTD III has thirty-eight approved drugs.

There are five tentative approvals on HETERO LABS LTD III drugs.

Summary for Hetero Labs Ltd Iii
US Patents:0
Tradenames:33
Ingredients:32
NDAs:38

Drugs and US Patents for Hetero Labs Ltd Iii

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hetero Labs Ltd Iii TADALAFIL tadalafil TABLET;ORAL 209908-004 Mar 26, 2019 AB1 RX No No   Start Trial   Start Trial
Hetero Labs Ltd Iii LEVETIRACETAM levetiracetam SOLUTION;ORAL 203052-001 Feb 28, 2013 AA RX No No   Start Trial   Start Trial
Hetero Labs Ltd Iii STAVUDINE stavudine CAPSULE;ORAL 078957-001 Dec 29, 2008 DISCN No No   Start Trial   Start Trial
Hetero Labs Ltd Iii TORSEMIDE torsemide TABLET;ORAL 079234-001 Jan 27, 2009 AB RX No No   Start Trial   Start Trial
Hetero Labs Ltd Iii TADALAFIL tadalafil TABLET;ORAL 209907-001 Feb 5, 2019 AB2 RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for HETERO LABS LTD III drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
AstraZeneca
Dow
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.